Annual report [Section 13 and 15(d), not S-K Item 405]

Earnings (Loss) Per Share and Stockholders' Equity, Narrative (Details)

v3.25.4
Earnings (Loss) Per Share and Stockholders' Equity, Narrative (Details)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Sep. 26, 2025
USD ($)
$ / shares
shares
Sep. 15, 2025
USD ($)
$ / shares
shares
Aug. 27, 2025
USD ($)
instrument
shares
Aug. 22, 2025
USD ($)
$ / shares
shares
Dec. 27, 2025
USD ($)
shares
Dec. 28, 2024
USD ($)
shares
Dec. 30, 2023
USD ($)
Sep. 27, 2025
USD ($)
Aug. 21, 2025
USD ($)
Dec. 31, 2022
USD ($)
Earnings Per Share [Abstract]                    
Securities excluded from the computation of diluted earnings per share (shares) | shares         153,000 114,000        
Subsidiary or Equity Method Investee [Line Items]                    
Proceeds to be received under government program       $ 3,200            
Warrant issuance, subsidiary ownership threshold percentage       51.00%            
Number of instruments issued | instrument     3              
Increase to total stockholders' equity         $ 126,360 $ 105,032 $ 109,965     $ 103,286
Not contingently issuable escrowed shares (in shares) | shares         78,000          
Contingently issuable escrowed shares (in shares) | shares         78,000          
Government incentives received                 $ 2,300  
Error Correction, Classification of Government Receipts                    
Subsidiary or Equity Method Investee [Line Items]                    
Decrease to total liabilities               $ 3,000    
Increase to total stockholders' equity               $ 3,000    
Not Designated as Hedging Instrument                    
Subsidiary or Equity Method Investee [Line Items]                    
Net loss due to change in fair value         $ 1,335 (422) (481)      
Shares In Escrow                    
Subsidiary or Equity Method Investee [Line Items]                    
Derivative liability         2,700          
Shares In Escrow | Not Designated as Hedging Instrument                    
Subsidiary or Equity Method Investee [Line Items]                    
Net loss due to change in fair value         $ 1,796 $ 0 $ 0      
Department of Commerce                    
Subsidiary or Equity Method Investee [Line Items]                    
Proceeds from issuance of common stock, warrants and escrowed shares     $ 5,700              
Stock to be issued (in shares) | shares       433,000            
Stock issued (in shares) | shares     275,000              
Stock issued into escrow (in shares) | shares     159,000              
Warrants issued (in shares) | shares     241,000              
Warrant exercise price (in dollars per share) | $ / shares       $ 20.00            
Stock to be issued, price per share (in dollars per share) | $ / shares       $ 20.00            
Stock released from escrow (in shares) | shares         3,000          
Private Placement                    
Subsidiary or Equity Method Investee [Line Items]                    
Sale of stock, shares sold (in shares) | shares 87,000                  
Sale of stock, price per share (in dollars per share) | $ / shares $ 23.00                  
Sale of stock, proceeds received $ 2,000                  
Shares of stock to be sold (in shares) | shares   215,000                
Price of stock to be sold (in dollars per share) | $ / shares   $ 23.28                
Consideration to be received upon sale of stock   $ 5,000